James Thomson is a Chanticleer columnist at The Australian Financial Review, with a focus on business and finance. With a background as the former editor of BRW and SmartCompany, James provides insights and analysis on investment, market trends, and the Australian business landscape.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Australia (National)
Not enough data
Not enough data
James Thomson's focus is on finance and economy, particularly investment analysis. He covers topics such as market analysis, business, CEOs, investments and the economy. Given this coverage emphasis, he would likely be most responsive to pitches offering in-depth financial analysis or insights from credible experts within the finance and investment sectors.
As James focuses on national coverage in Australia, relevant pitches should consider how any discussed topics may specifically relate to or impact the Australian market. For example, insights into long-term stock picks with a specific relevance to Australian investors could be of interest.
Pitches that offer unique data-driven perspectives related to his themes covered might also resonate well with him based on his reported citation of data in nearly a quarter of his articles.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: James Thomson
Charter Hall boss David Harrison says the supply shortages and lack of developer confidence we’re seeing in the housing market are playing out across the property sector.
By: James Thomson
China’s spluttering stimulus and strong production means the market for the steel-making ingredient will move further into oversupply next year. That’s bad news for miners and the federal government.
The fact the chipmaker’s profit report was billed as “the most important earnings report ever” isn’t exactly a sign of healthy global markets.
By: James Thomson
For the past few years, Raphael Arndt has warning about the dangers posed to investors by government intervention. Now he’s getting real-life experience.
By: James Thomson
The company’s managing director says he knows it’s time to go in 18 months. But like the man himself, some investors see him as the miner’s beating heart.
By: Kylar Loussikian, James Thomson
The decision to terminate a contract not expected to end until 2026 means the insurer’s customers will have to pay more to use the company’s 38 hospitals.
By: James Thomson
We read next year’s outlook statements from the likes of Goldman Sachs, UBS, JPMorgan and Morgan Stanley so you don’t have to. Here are the gems we found.
Australians have a right to expect that the massive superannuation industry can get its administration in order. The clock is ticking as more Australians retire.
By: James Thomson
Hospital operators and health insurers love ramping up the rhetoric. But the long-term problems of health policy in this country aren’t getting fixed.
By: James Thomson
Operators including Brookfield-owned Healthscope and ASX-listed Ramsay Health Care want the radical change and say facilities will close if they are not funded.
(833) 317-6278 
